VeriMomhydrogenated bisabolol hamilelikte güvenli mi?
No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR repro warnings for hydrogenated bisabolol were identified. CIR assessments and SCCS opinions cover bisabolol/related cosmetic use and conclude safety 'as used' for topical applications; peer‑reviewed literature (PubMed) does not report teratogenic or reproductive effects for hydrogenated bisabolol. Therefore default hazard/mechanism scores are 0 and dermal exposure from normal cosmetic use is considered negligible (evidence: CIR; SCCS where applicable; PubMed; ECHA Annex VI).
Related ingredients
Frequently asked questions
- hydrogenated bisabolol hamilelikte güvenli mi?
- No harmonised CLP reproductive classification (ECHA Annex VI) or SCCS/CIR repro warnings for hydrogenated bisabolol were identified. CIR assessments and SCCS opinions cover bisabolol/related cosmetic use and conclude safety 'as used' for topical applications; peer‑reviewed literature (PubMed) does not report teratogenic or reproductive effects for hydrogenated bisabolol. Therefore default hazard/mechanism scores are 0 and dermal exposure from normal cosmetic use is considered negligible (evidence: CIR; SCCS where applicable; PubMed; ECHA Annex VI).
- hydrogenated bisabolol emzirirken güvenli mi?
- No data indicating reproductive or lactation hazards, no harmonised classification, and no studies showing transfer into breastmilk. With topical cosmetic use the expected systemic exposure is negligible; therefore hazard and mechanism scores are 0 and exposure scored as negligible (sources: CIR/SCCS coverage of bisabolol class, PubMed, ECHA Annex VI, PubChem/CosIng listings).
- hydrogenated bisabolol bebek cildi için güvenli mi?
- No infant‑specific reproductive or toxicity data found and no harmonised flags; hazard and mechanism remain 0. Per guidance, exposure for 0–3 yr skin is increased by +1 relative to adults because infant skin has greater absorption and surface‑area/weight, so exposure scored 1. Safety as used in cosmetics is supported by CIR/SCCS discussion of bisabolol derivatives; no infant‑specific adverse reports located (sources: CIR, SCCS/preferred opinions for bisabolol class; PubMed; CosIng; EWG).
- VeriMom hydrogenated bisabolol nasıl puanlıyor?
- VeriMom hydrogenated bisabolol'yi EU CosIng, ECHA sınıflandırmaları ve PubMed çalışmalarına göre 100/100 (bilinen risk yok) olarak puanlar.
- Hamilelikte hydrogenated bisabolol yerine neler kullanılabilir?
- Benzer işlevli ve bilinen riski olmayan alternatifleri içeren listemize bakın.
Her etiketi 2 saniyede kontrol et
VeriMom'u ücretsiz indirin — herhangi bir ürünü tarayın ve hamilelik güvenlik puanını anında görün.
Tıbbi Sorumluluk Reddi
Bu bilgiler yalnızca eğitim amaçlıdır ve tıbbi tavsiye niteliği taşımaz. Güvenlik puanları kamuya açık verilere dayanmaktadır ve tüm riskleri yansıtmayabilir. Hamilelik veya emzirme döneminde herhangi bir ürünü kullanmadan önce her zaman sağlık uzmanınıza danışın.